Check out the companies making headlines in midday trading. Fortinet — Shares jumped more than 7% after TD Cowen upgraded the cybersecurity stock to buy from hold, saying rising memory prices won’t hurt the company as much as some suspect. The firm’s $100 price target suggests 29% upside ahead. Bausch Health — The pharmaceutical stock fell 9% after one of its experimental treatments missed targets in a late-stage clinical trial. Bausch was working on a treatment for hepatic encephalopathy, a condition where toxins build up in the blood, hurting brain function, in patients with liver disease. Moderna — The biotech’s stock pulled back 6%, breaking a four-day win streak. The move follows CEO Stephane Bancel telling Bloomberg TV that the company doesn’t plan on investing in new late-stage vaccine trials due to U.S. opposition to immunizations. Intel — Shares fell 16% after Intel reported mixed fourth-quarter results and issued a weak forecast. Intel expects first-quarter revenue will be between $11.7 billion and $12.7 billion, with adjusted profit breaking even. Analysts surveyed by LSEG expected the chipmaker to earn 5 cents per share on $12.51 billion in revenue. Clorox — The maker of household cleaning products rose almost 3% after it agreed to acquire Gojo Industries , the manufacturer of Purell, for $2.25 billion. Excluding the impact of the purchase, Clorox re …
